Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 2/2018

Ausgabe 2/2018

Inhaltsverzeichnis ( 15 Artikel )

20.10.2017 | Review | Ausgabe 2/2018

Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?

Joseph M. Obeid, Paul R. Kunk, Victor M. Zaydfudim, Timothy N. Bullock, Craig L. Slingluff Jr., Osama E. Rahma

10.10.2017 | Original Article | Ausgabe 2/2018

Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignancies

Kristina Buder-Bakhaya, Karolina Benesova, Carsten Schulz, Hoda Anwar, Antonia Dimitrakopoulou-Strauss, Tim F. Weber, Alexander Enk, Hanns-Martin Lorenz, Jessica C. Hassel

12.10.2017 | Original Article | Ausgabe 2/2018

A filamentous bacteriophage targeted to carcinoembryonic antigen induces tumor regression in mouse models of colorectal cancer

Paola Murgas, Nicolás Bustamante, Nicole Araya, Sebastián Cruz-Gómez, Eduardo Durán, Diana Gaete, César Oyarce, Ernesto López, Andrés Alonso Herrada, Nicolás Ferreira, Hans Pieringer, Alvaro Lladser

17.10.2017 | Original Article | Ausgabe 2/2018

Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice

Jill P. Smith, Shangzi Wang, Sandeep Nadella, Sandra A. Jablonski, Louis M. Weiner

20.10.2017 | Original Article | Ausgabe 2/2018

Clinicopathologic implications of CD8+/Foxp3+ ratio and miR-574-3p/PD-L1 axis in spinal chordoma patients

Ming-Xiang Zou, Ke-Miao Guo, Guo-Hua Lv, Wei Huang, Jing Li, Xiao-Bin Wang, Yi Jiang, Xiao-Ling She

20.10.2017 | Original Article | Ausgabe 2/2018

Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia

Nina Rolf, Kinga K. Smolen, Amina Kariminia, Adam Velenosi, Mario Fidanza, Caron Strahlendorf, Alix E. Seif, Gregor S. D. Reid

20.10.2017 | Original Article | Ausgabe 2/2018 Open Access

NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma

Zhenjiang Liu, Thomas Poiret, Oscar Persson, Qingda Meng, Lalit Rane, Jiri Bartek Jr., Julia Karbach, Hans-Michael Altmannsberger, Christopher Illies, Xiaohua Luo, Inti Harvey-Peredo, Elke Jäger, Ernest Dodoo, Markus Maeurer

24.10.2017 | Original Article | Ausgabe 2/2018

A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice

Timothy S. Fisher, Andrea T. Hooper, Justin Lucas, Tracey H. Clark, Allison K. Rohner, Bryan Peano, Mark W. Elliott, Konstantinos Tsaparikos, Hui Wang, Jonathan Golas, Maria Gavriil, Nahor Haddish-Berhane, Lioudmila Tchistiakova, Hans-Peter Gerber, Adam R. Root, Chad May

31.10.2017 | Original Article | Ausgabe 2/2018

CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer

Yichou Wei, Chao Lin, He Li, Zhiying Xu, Jieti Wang, Ruochen Li, Hao Liu, Heng Zhang, Hongyong He, Jiejie Xu

31.10.2017 | Original Article | Ausgabe 2/2018

Cross-talk between TNF-α and IFN-γ signaling in induction of B7-H1 expression in hepatocellular carcinoma cells

Na Li, Jianing Wang, Na Zhang, Mengwei Zhuang, Zhaoyun Zong, Jiahuan Zou, Guosheng Li, Xiaoyan Wang, Huaiyu Zhou, Lining Zhang, Yongyu Shi

01.11.2017 | Original Article | Ausgabe 2/2018

A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients

Olivier Gasser, Katrina J. Sharples, Catherine Barrow, Geoffrey M. Williams, Evelyn Bauer, Catherine E. Wood, Brigitta Mester, Marina Dzhelali, Graham Caygill, Jeremy Jones, Colin M. Hayman, Victoria A. Hinder, Jerome Macapagal, Monica McCusker, Robert Weinkove, Gavin F. Painter, Margaret A. Brimble, Michael P. Findlay, P. Rod Dunbar, Ian F. Hermans

01.11.2017 | Original Article | Ausgabe 2/2018

BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma

Qi Liu, Hongda Zhu, Yun Liu, Sara Musetti, Leaf Huang

20.10.2017 | Original Article | Ausgabe 2/2018

Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells

Tamson Moore, Courtney Regan Wagner, Gina M. Scurti, Kelli A. Hutchens, Constantine Godellas, Ann Lau Clark, Elizabeth Motunrayo Kolawole, Lance M. Hellman, Nishant K. Singh, Fernando A. Huyke, Siao-Yi Wang, Kelly M. Calabrese, Heather D. Embree, Rimas Orentas, Keisuke Shirai, Emilia Dellacecca, Elizabeth Garrett-Mayer, Mingli Li, Jonathan M. Eby, Patrick J. Stiff, Brian D. Evavold, Brian M. Baker, I. Caroline Le Poole, Boro Dropulic, Joseph I. Clark, Michael I. Nishimura

20.12.2017 | Correction | Ausgabe 2/2018

Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells

Tamson Moore, Courtney Regan Wagner, Gina M. Scurti, Kelli A. Hutchens, Constantine Godellas, Ann Lau Clark, Elizabeth Motunrayo Kolawole, Lance M. Hellman, Nishant K. Singh, Fernando A. Huyke, Siao-Yi Wang, Kelly M. Calabrese, Heather D. Embree, Rimas Orentas, Keisuke Shirai, Emilia Dellacecca, Elizabeth Garrett-Mayer, Mingli Li, Jonathan M. Eby, Patrick J. Stiff, Brian D. Evavold, Brian M. Baker, I. Caroline Le Poole, Boro Dropulic, Joseph I. Clark, Michael I. Nishimura

08.01.2018 | Correction | Ausgabe 2/2018

Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy

Xiaopeng Yuan, Mingjuan Yang, Xiang Chen, Xuhua Zhang, Shrey Sukhadia, Najia Musolino, Huijing Bao, Tingtao Chen, Chen Xu, Qirui Wang, Stephen Santoro, Daniel Ricklin, Jia Hu, Ruihe Lin, Wei Yang, Zhijun Li, Weijun Qin, Aizhi Zhao, Nathalie Scholler, George Coukos

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise